Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · IEX Real-Time Price · USD
6.70
+0.08 (1.21%)
Feb 26, 2024, 1:32 PM EST - Market open

Sagimet Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Selling, General & Admin
6.144.38
Research & Development
24.9219.34
Operating Expenses
31.0623.72
Operating Income
-31.06-23.72
Other Expense / Income
-0.560.72
Pretax Income
-30.5-24.44
Net Income
-30.5-24.44
Shares Outstanding (Basic)
1510
Shares Outstanding (Diluted)
1510
Shares Change
50.61%-
EPS (Basic)
-2.08-2.51
EPS (Diluted)
-2.08-2.51
Free Cash Flow
-24.49-21.71
Free Cash Flow Per Share
-1.67-2.23
EBITDA
-30.37-24.31
Depreciation & Amortization
0.130.13
EBIT
-30.5-24.44
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).